Market news — every asset we track

Assets

SNOA

Sonoma Pharmaceuticals cancels special meeting due to lack of quorum

Aug 19Investing.com

SNOA

Sonoma Pharmaceuticals reports 60% revenue growth in Q1

Aug 6Investing.com

SNOA

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

Total revenue increased 60% year over year to $6.4 million Net loss per share decreased 88% compared to the prior-year quarter Gross margin expanded to 40% as operating expenses remained stable FDA clearance and new global distributors support continued ...

Aug 6finance.yahoo.com

SNOA

This is the newest page. Registered accounts read further back.